Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55611-62-6

55611-62-6

Post Buying Request

55611-62-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55611-62-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 55611-62-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,6,1 and 1 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 55611-62:
(7*5)+(6*5)+(5*6)+(4*1)+(3*1)+(2*6)+(1*2)=116
116 % 10 = 6
So 55611-62-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H19NO/c11-8-7-10-9-5-3-1-2-4-6-9/h9-11H,1-8H2

55611-62-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(cycloheptylamino)ethanol

1.2 Other means of identification

Product number -
Other names 2-(cycloheptylamino)ethan-1-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55611-62-6 SDS

55611-62-6Downstream Products

55611-62-6Relevant articles and documents

LIPID NANOPARTICLE COMPOSITION

-

Paragraph 00381, (2021/10/15)

Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination.

Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents

-

Page column 86, (2010/02/05)

This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55611-62-6